Calithera Biosciences, Inc. (CALA)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
-0.0009 (-90.00%)
Dec 26, 2024, 4:00 PM EST
Calithera Biosciences Company Description
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023.
Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business.
Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Calithera Biosciences, Inc.
| Country | United States |
| Founded | 2010 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 9 |
Contact Details
Address: 343 Oyster Point Boulevard South San Francisco, Delaware 94080 United States | |
| Phone | 650 870 1000 |
| Website | calithera.com |
Stock Details
| Ticker Symbol | CALA |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US13089P5070 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Stephanie Wong CPA | Chief Financial Officer and Secretary |
| Dr. Christopher J. Molineaux Ph.D. | Senior Vice President of Development |
| Frank Parlati Ph.D. | Senior Vice President of Research |